Central nervous system manifestations of COVID-19: A systematic review
Good article in the Journal of the Neurological Sciences June 16, 2020 In this systematic review, we will discuss the evidence on the occurrence of central nervous system (CNS) involvement and neurological manifestations in patients with COVID-19. Results Through the search strategy, we could identify two articles about neurological involvement by COVID-19. One of these publications […]
CMS Finalizes Medicare Coverage Policy for Monoclonal Antibodies
CMS Finalizes Medicare Coverage Policy for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease Decision Follows Robust Stakeholder Input and Creates Pathway for Enhanced Access and Coverage of Drugs that Receive Traditional FDA Approval Treatment for Alzheimer’s Disease Today, the Centers for Medicare & Medicaid Services (CMS) released a national policy for […]
Sotrovimab Monoclonal Antibody Treatment for COVID-19
As of April 5, 2022, the U.S. Food and Drug Administration (FDA) reissued the emergency use authorization (EUA) for GSK-Vir Biotechnology’s sotrovimab monoclonal antibody treatment. It is important to note Sotrovimab is no longer authorized for use within the U. S. The full FDA press release can be read at FDA updates Sotrovimab emergency use […]
Patterns of Potential Moral Injury in Post-9/11 Combat Veterans and COVID-19 Healthcare Workers
“Moral injury has been defined as the “psychological, biological, spiritual, behavioral and social impact of perpetrating, failing to prevent, or bearing witness to acts that transgress deeply held moral beliefs and expectations.”1 Since this definition was introduced in 2009, the subsequent decade of research focused almost exclusively on military veterans. Among military personnel, the killing of […]
New Recommendations for Use of 15-Valent and 20-Valent Pneumococcal Conjugant Vaccine, 2022
What is already known about this topic? Currently, the 13-valent pneumococcal conjugate vaccine (PCV) (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPSV23) are recommended for U.S. adults. Recommendations vary by age and risk groups. What is added by this report? On October 20, 2021, the Advisory Committee on Immunization Practices recommended 15-valent PCV (PCV15) or […]
Get free at-home COVID-19 tests
It’s time to order you free COVID-19 tests. Key things to remember is: If you are symptomatic, and your rapid test is negative you should follow it up with a PCR test. Rapid tests have a harder time picking up Omicron. When in doubt get advice from your physician. Get vaccinated now don’t wait until […]
Vestex Scrubs might be able to protect you from taking COVID-19 home
FDA currently reviewing the ability of VESTEX® to reduce COVID-19. While the FDA has not yet reviewed the ability of products protected by VESTEX® to reduce COVID-19, preliminary research has documented results equal to or better than the reduction of MRSA. This research is being assessed analytically and VESTEX® does intend to seek FDA clearance for specific claims […]
VESTEX Scrubs, T-shirts and Jackets to protect you from fluid, bacteria, and viruses.
Don’t risk taking body fluids, bacteria or viruses home anymore. VESTEX is the company to go to. They are approved by the FDA and work the way advertise. They are worth every penny. Tried, Tested and Loved. The global VESTEX® brand franchise has been in development for over a decade. For thousands of consumers around the […]
Guidance for the Interim Final Rule – Medicare and Medicaid Programs; Omnibus COVID-19 Health Care Staff Vaccination
Memo # QSO-22-07-ALL Posting Date 2021-12-28 Fiscal Year 2022 Summary CMS is committed to ensuring America’s healthcare facilities respond effectively in an evidence-based way to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (PHE). •On November 05, 2021, CMS published an interim final rule with comment period (IFC). This rule establishes requirements regarding COVID-19 vaccine […]
Ranking Seven COVID-19 Antigen Tests by Ease of Use: Report
Some COVID-19 rapid antigen home test kits are much easier to use than others, according to an analysis by ECRI, an independent, nonprofit patient safety organization. ECRI evaluated seven rapid COVID-19 antigen tests available for purchase online and in retail stores since December. None of the tests were rated as “excellent” in terms of usability and some […]
Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2
As of December 23, 2021 Due to concerns about increased transmissibility of the SARS-CoV-2 Omicron variant, this guidance is being updated to enhance protection for healthcare personnel (HCP), patients, and visitors, and to address concerns about potential impacts on the healthcare system given a surge of SARS-CoV-2 infections. These updates will be refined as additional information […]
Counterfeit Respirators / Misrepresentation of NIOSH-Approval
Counterfeit respirators are products that are falsely marketed and sold as being NIOSH-approved and may not be capable of providing appropriate respiratory protection to workers. When NIOSH becomes aware of counterfeit respirators or those misrepresenting NIOSH approval on the market, we will post them here to alert users, purchasers, and manufacturers. To read more go to:https://www.cdc.gov/niosh/npptl/usernotices/counterfeitResp.html
Postcards From the Edge: Lessons Taught by COVID-19
One thing that will haunt me and many health care personnel in both acute care and LTCFs forever is that so many people died without a family member at their bedside. I reached out to people in different disciplines, settings, and states. I wanted to know what lessons we’ve learned from the carnage caused by […]
This Way to the OR, Infection Preventionists
Many infection preventionists trust that everyone working in the operating room knows what they are doing and many times shy away from going into the OR. That’s a mistake. In fall 2016, I was on my way to work at 8 AM on a Monday when my cell phone rang. It was the surgical department […]
Early Release – Postmortem Antigen-Detecting Rapid Diagnostic Tests to Predict Infectivity of SARS-CoV-2–Associated Deaths – Volume 28, Number 1—January 2022 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: University Medical Center Hamburg-Eppendorf, Hamburg, Germany Deaths associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have raised concerns that contact with the corpses of […]